Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Recurrent Squamous Cell Lung Carcinoma × telisotuzumab vedotin × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Neoplasms 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡